
@ShahidNShah
Both healthcare delivery organizations (HDOs) and start-ups have much to gain from collaboration, but corporate venture capital investments need a clear strategy, focus, and operating model.
What separates the best corporate–start-up collaborations from those that get stuck in “pilot purgatory” is a clear and aligned strategy, the selection of the right candidates, and a shared road map for execution and scale. Companies should define success clearly, assess use cases and operating constraints, and choose the right operating model. By following these best practices, established corporations can successfully embrace the power of disruption. The alternative, one CVC executive noted, is to “be disrupted by someone else.”
Continue reading at mckinsey.com
The Consumer Technology Association (CTA) awards Abbott multiple CES 2023 Innovation Awards for industry-leading health technologiesAbbott's Aveir™ single-chamber (VR) leadless pacemaker, Proclaim™ …
Posted Nov 19, 2022 Artificial Intelligence Media (Press) Release
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2025 Netspective Foundation, Inc. All Rights Reserved.
Built on Feb 21, 2025 at 1:11pm